Literature DB >> 17786553

Alpha 2A-adrenoceptor-specific stimulation of [35S]GTP gamma S binding to membrane preparations of rat frontal cortex.

Oliver Pulges1, Ago Rinken.   

Abstract

Functional activation of alpha 2A adrenergic receptors in the crude membranes from rat frontal cortex was studied by a [35S]-guanosine 5'-O-(gamma-thiotriphosphate) ([35S]GTP gamma S) binding assay. alpha 2A agonists UK14304 and guanfacine decreased the ability of GDP to compete with [35S]GTP gamma S binding to the membranes and 0.1 mM GDP was found to be optimal for the following functional experiments. However, even after careful optimization of experimental conditions the specificity of ligands for rat alpha 2 adrenoceptors were not sufficient, as agonists as well as antagonists became activators of other signal transduction systems before achieving their maximal effect in the alpha 2A-adrenergic system. Only using compromising concentration of agonist (up to 1 microM UK14304) and antagonist (up to 1 microM RS79948) to inhibit agonist's effect, allowed us to filtrate out alpha 2A specific effect for characterization of signal transduction in rat frontal cortex membranes for the comparison efficacies of this system for different animals from behavioral experiments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786553     DOI: 10.1007/s11064-007-9457-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins.

Authors:  D P McEwen; K R Gee; H C Kang; R R Neubig
Journal:  Anal Biochem       Date:  2001-04-01       Impact factor: 3.365

2.  Serotonergic agonists behave as partial agonists at the dopamine D2 receptor.

Authors:  A Rinken; S Ferré; A Terasmaa; C Owman; K Fuxe
Journal:  Neuroreport       Date:  1999-02-25       Impact factor: 1.837

Review 3.  An overview on functional receptor autoradiography using [35S]GTPgammaS.

Authors:  J Sóvágó; D S Dupuis; B Gulyás; H Hall
Journal:  Brain Res Brain Res Rev       Date:  2001-12

4.  Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors.

Authors:  Valérie Audinot; Nelly Fabry; Jean-Paul Nicolas; Philippe Beauverger; Adrian Newman-Tancredi; Mark J Millan; Anne Try; Frédéric Bornancin; Emmanuel Canet; Jean A Boutin
Journal:  Cell Signal       Date:  2002-10       Impact factor: 4.315

5.  Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.

Authors:  Sergei Kopanchuk; Santa Veiksina; Ramona Petrovska; Ilze Mutule; Michael Szardenings; Ago Rinken; Jarl E S Wikberg
Journal:  Eur J Pharmacol       Date:  2005-04-11       Impact factor: 4.432

6.  Characterization of M2 muscarinic receptor activation of different G protein subtypes.

Authors:  Ain Uustare; Johnny Näsman; Karl E O Akerman; Ago Rinken
Journal:  Neurochem Int       Date:  2004-01       Impact factor: 3.921

7.  Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.

Authors:  John R Traynor; Mary J Clark; Ann E Remmers
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

Review 8.  Subtypes of functional alpha1- and alpha2-adrenoceptors.

Authors:  J R Docherty
Journal:  Eur J Pharmacol       Date:  1998-11-13       Impact factor: 4.432

9.  Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.

Authors:  A Newman-Tancredi; J P Nicolas; V Audinot; S Gavaudan; L Verrièle; M Touzard; C Chaput; N Richard; M J Millan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-08       Impact factor: 3.000

10.  Characteristics of binding of [3H]WAY100635 to rat hippocampal membranes.

Authors:  Sven Parkel; Ago Rinken
Journal:  Neurochem Res       Date:  2006-08-26       Impact factor: 4.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.